Cargando…

Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma

Dendritic cell (DC)-based immunotherapy has yielded promising results against high-grade glioma (HGG). However, the efficacy of DC vaccines is abated by HGG-induced immunosuppression and lack of attention toward the immunogenicity of the tumor lysate/cells used for pulsing DCs. A literature analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vandenberk, Lien, Garg, Abhishek D., Verschuere, Tina, Koks, Carolien, Belmans, Jochen, Beullens, Monique, Agostinis, Patrizia, De Vleeschouwer, Steven, Van Gool, Stefaan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801426/ https://www.ncbi.nlm.nih.gov/pubmed/27057467 http://dx.doi.org/10.1080/2162402X.2015.1083669

Ejemplares similares

Irradiation of necrotic tumor cells used to pulse dendritic cells (DCs) potentiates DC vaccine-induced anti-tumor immunity in a mouse model of high-grade glioma
por: Vandenberk, Lien, et al.
Publicado: (2014)

Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
por: Vandenberk, Lien, et al.
Publicado: (2016)

Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?
por: Koks, Carolien A.E., et al.
Publicado: (2015)

Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
por: Van Woensel, Matthias, et al.
Publicado: (2017)

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
por: Schaaf, Marco B., et al.
Publicado: (2018)

Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity
por: Dudek, Aleksandra M., et al.
Publicado: (2013)

Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
por: Decraene, Brecht, et al.
Publicado: (2022)

Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
por: Decraene, Brecht, et al.
Publicado: (2022)

Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response
por: Dejaegher, Joost, et al.
Publicado: (2014)

Human CD141(+) (BDCA-3)(+) dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
por: Jongbloed, Sarah L., et al.
Publicado: (2010)

Editorial: Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality
por: Garg, Abhishek D., et al.
Publicado: (2016)

Diversifying the platinum-based chemotherapy toolkit for immunogenic cancer cell death
por: Garg, Abhishek D., et al.
Publicado: (2020)

The “Yin and Yang” of Unfolded Protein Response in Cancer and Immunogenic Cell Death
por: Rufo, Nicole, et al.
Publicado: (2022)

Depletion of Regulatory T Cells in a Mouse Experimental Glioma Model through Anti-CD25 Treatment Results in the Infiltration of Non-Immunosuppressive Myeloid Cells in the Brain
por: Maes, Wim, et al.
Publicado: (2013)

DCs facilitate B cell responses against microbial DNA via DC-SIGN
por: Sprokholt, Joris K., et al.
Publicado: (2017)

Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity
por: Garg, Abhishek D, et al.
Publicado: (2013)

Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs
por: Ouaguia, Laurissa, et al.
Publicado: (2020)

Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival
por: Belmans, Jochen, et al.
Publicado: (2017)

Melanoma immunotherapy
por: Garg, Abhishek D., et al.
Publicado: (2015)

The emergence of phox-ER stress induced immunogenic apoptosis
por: Garg, Abhishek D., et al.
Publicado: (2012)

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
por: Adkins, Irena, et al.
Publicado: (2015)

Drug-induced ciliogenesis in pancreatic cancer cells is facilitated by the secreted ATP-purinergic receptor signaling pathway
por: Khan, Niamat Ali, et al.
Publicado: (2017)

Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress
por: Garg, Abhishek D, et al.
Publicado: (2014)

Antitumor immunity induced by VE-cadherin modified DC vaccine
por: Zhou, Jing, et al.
Publicado: (2017)

Unraveling Sugar Binding Modes to DC-SIGN by Employing Fluorinated Carbohydrates
por: Martínez, J. Daniel, et al.
Publicado: (2019)

NK-pDC cross-talk leads to the generation of mTRAIL+IFN-α+cytotoxic pDCs following HIV-1 infection of pDCs. Consequences on the control of viral replication
por: Saïdi, Héla, et al.
Publicado: (2010)

DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis
por: Vedunova, Maria, et al.
Publicado: (2022)

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells
por: Romano, Erminia, et al.
Publicado: (2018)

Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells
por: Romano, Erminia, et al.
Publicado: (2018)

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
por: Laureano, Raquel S, et al.
Publicado: (2022)

Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
por: van Woensel, Matthias, et al.
Publicado: (2013)

BDCA1(+) cDC2s, BDCA2(+) pDCs and BDCA3(+) cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2020)

CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity
por: Li, Yifan, et al.
Publicado: (2019)

Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth
por: Mathivet, Thomas, et al.
Publicado: (2017)

P19-19. MVA vaccines are efficiently cross-presented by DCs and do not enhance HIV replication in DC/T cell cultures
por: Brandler, S, et al.
Publicado: (2009)

Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets
por: Wimmers, Florian, et al.
Publicado: (2014)

Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection
por: Bosteels, Cedric, et al.
Publicado: (2020)

New role for antigen-presenting activated pDCs in promoting Th17 cells and impacting antitumor immunity
por: Guéry, Leslie, et al.
Publicado: (2015)

Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors
por: Jin, Chuan, et al.
Publicado: (2014)

CD24 (+) MDSC-DCs Induced by CCL5-Deficiency Showed Improved Antitumor Activity as Tumor Vaccines
por: Huang, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mdu35v26q4ihmnrti9ssi0t7d5